Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker
- This topic has 0 replies, 1 voice, and was last updated 7 years, 8 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract.
https://www.ncbi.nlm.nih.gov/pubmed/27999621
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.